In this issue, I particularly recommend the article on the treatment of proctological patients with immunodeficiency. Currently, we increasingly encounter immunocompromised patients in our medical practice. Most of them are oncology patients (as many as 30% of oncology patients experience proctological disease) who receive chemotherapy. The remainder are patients receiving biological therapy for inflammatory bowel disease, those receiving long-term immunosuppressive medications after organ transplantation, and those with acquired immunodeficiency syndrome due to HIV infection. The authors present three case studies, which serve as a context for discussing the treatment of these patients. This article is particularly valuable because its authors work daily in a department where organ transplants are performed, thus presenting their practical observations on patients receiving long-term immunosuppressive therapy.

I also recommend reading an overview article on the treatment of pilonidal cysts using the Gips procedure. Although this method is not new (it was first described in 2008 by Moshe Gips), but it is not popular in Poland. It is a certain alternative in the treatment of patients with pilonidal cysts. It is minimally invasive and can also be performed in an outpatient setting, which makes it an attractive therapeutic option. However, it seems that, as with any other surgical method, the key to therapeutic success with the Gips procedure is the appropriate qualification of patients with pilonidal cysts.